Printer Friendly

/C O R R E C T I O N -- AMERICAN BIOGENETIC SCIENCES, INC./

 /C O R R E C T I O N -- AMERICAN BIOGENETIC SCIENCES, INC./
 In NY013, American Biogenetic Sciences Receivers U.S. Patent For Blood Clot Detection Antibody, moved earlier today, the fifth graph, third line should read "The FDA has already approved a diagnostic kit utilizing another proprietary ABS antibody for measuring fibrinogen" rather than "The FDA has ... a diagnostic it utilizing ..." as originally transmitted.
 -0- 6/1/92 C NY013
 (MABXA) CO: American Biogenetic Sciences, Inc. ST: Indiana IN: MTC SU:


TS-OS -- NY013A -- 5613 06/01/92 11:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 1, 1992
Words:92
Previous Article:AETNA OFFERS FREE INSPECTION GUIDE FOR HOME BUYERS, 'BEFORE A HOUSE BECOMES A HOME'
Next Article:BRECK GIRLS SMILE AGAIN AS DIAL CORP UNVEILS 'BRECK GIRL HALL OF FAME'; COMPANY ANNOUNCES SEARCH FOR FORMER BRECK GIRLS
Topics:


Related Articles
AMERICAN BIOGENETIC SCIENCES SIGNS LICENSE AGREEMENT WITH YAMANOUCHI PHARMACEUTICAL
CHANGE IN PRESIDENCY OF AMERICAN BIOGENETIC SCIENCES
AMERICAN BIOGENETIC SCIENCES RECEIVES U.S. PATENT FOR BLOOD CLOT DETECTION ANTIBODY
AMERICAN BIOGENETIC SCIENCES, INC. FILES WITH THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR 510(k) PRE-MARKET CLEARANCE
AMERICAN BIOGENETIC SCIENCES, INC. RESPONDS TO INVESTOR INQUIRIES
American Biogenetic Sciences, Inc. and Gull Laboratories, Inc. Announce Strategic Alliance on Product Manufacture and Distribution
American Biogenetic Sciences, Inc. Submits 510(k) to FDA for Marketing Clearance of Fibrinogen Blood Test, FiF
American Biogenetic Sciences Signs Agreement with Shield Diagnostics for Distribution of TpP Kit in the UK
American Biogenetic Sciences, Inc.Signs Agreement with Trevigen, Inc. To Produce Mabs Using Antigen Free Technology
Patients With HIV-Associated Wasting Gain More Weight With Concentrated Form of Megestrol Acetate, Study Shows.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters